ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $13,515,000 | +683.0% | 292,400 | +162.0% | 0.07% | +580.0% |
| Q1 2019 | $1,726,000 | -23.5% | 111,600 | -28.6% | 0.01% | -33.3% |
| Q4 2018 | $2,256,000 | +30.7% | 156,200 | +40.0% | 0.02% | +50.0% |
| Q3 2018 | $1,726,000 | -10.8% | 111,600 | -2.5% | 0.01% | -23.1% |
| Q2 2018 | $1,935,000 | -37.4% | 114,500 | -39.7% | 0.01% | -38.1% |
| Q1 2018 | $3,093,000 | +263.9% | 190,000 | +100.8% | 0.02% | +200.0% |
| Q4 2017 | $850,000 | 0.0% | 94,600 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $850,000 | +6.4% | 94,600 | 0.0% | 0.01% | +16.7% |
| Q2 2017 | $799,000 | -7.0% | 94,600 | 0.0% | 0.01% | -25.0% |
| Q1 2017 | $859,000 | +41.7% | 94,600 | +35.1% | 0.01% | +33.3% |
| Q4 2016 | $606,000 | +206.1% | 70,000 | +2.9% | 0.01% | +200.0% |
| Q1 2016 | $198,000 | -34.0% | 68,000 | -6.1% | 0.00% | -33.3% |
| Q4 2015 | $300,000 | -7.1% | 72,400 | +2.1% | 0.00% | -25.0% |
| Q3 2015 | $323,000 | -34.1% | 70,900 | +4.4% | 0.00% | -33.3% |
| Q2 2015 | $490,000 | +1.7% | 67,900 | +3.8% | 0.01% | 0.0% |
| Q1 2015 | $482,000 | +42.6% | 65,400 | -7.8% | 0.01% | +50.0% |
| Q4 2014 | $338,000 | +22.5% | 70,900 | -8.4% | 0.00% | 0.0% |
| Q3 2014 | $276,000 | -16.4% | 77,400 | +6.9% | 0.00% | -20.0% |
| Q2 2014 | $330,000 | -8.1% | 72,400 | -5.2% | 0.01% | -16.7% |
| Q1 2014 | $359,000 | +10.1% | 76,400 | +14.2% | 0.01% | +20.0% |
| Q4 2013 | $326,000 | -19.9% | 66,900 | +2.3% | 0.01% | -28.6% |
| Q3 2013 | $407,000 | – | 65,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|